Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator

NCT03131700 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Decision of the Sponsor

Conditions

Healthy

Interventions

BIOLOGICAL: RPH001
BIOLOGICAL: Avastin®

Sponsor

TRPHARM